Who
Ajay Royan
Director
Company insider
Files Form 4 as: Director and 10% owner, Fractyl Health; Director and 10% owner, Invivyd.
In numbers
- Trades disclosed
- 25
- Buys
- 4
- Sells
- 0
- Bought
- $39.0M
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 5 Aug 2021
- Last trade
- 12 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Jun 2026filed 15 Jun 2026 | GUTS Fractyl HealthMedical Devices | SEC FORM 4 Bought | $20K23,000 at $0.852 | filing |
| 12 Jun 2026filed 15 Jun 2026 | GUTS Fractyl HealthMedical Devices | SEC FORM 4 Bought | $20K23,000 at $0.85 | filing |
| 10 Jun 2026filed 11 Jun 2026 | GUTS Fractyl Healthoption or derivative · Medical Devices | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 10 Jun 2026filed 11 Jun 2026 | GUTS Fractyl Healthoption or derivative · Medical Devices | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | IVVD Invivydoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | IVVD Invivydoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 11 Jun 2025filed 13 Jun 2025 | GUTS Fractyl Healthoption or derivative · Medical Devices | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 20 May 2025filed 22 May 2025 | IVVD Invivydoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,219 at $0.00 | filing |
| 24 Mar 2025filed 26 Mar 2025 | IVVD Invivydoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 14 Mar 2025filed 18 Mar 2025 | GUTS Fractyl HealthMedical Devices | SEC FORM 4 Bought | $23K17,901 at $1.28 | filing |
| 6 Feb 2024filed 8 Feb 2024 | GUTS Fractyl Healthoption or derivative · Medical Devices | SEC FORM 4 Code C | —4,025,764 | filing |
| 6 Feb 2024filed 8 Feb 2024 | GUTS Fractyl Healthoption or derivative · Medical Devices | SEC FORM 4 Code C | —6,502,796 | filing |
| 6 Feb 2024filed 8 Feb 2024 | GUTS Fractyl Healthoption or derivative · Medical Devices | SEC FORM 4 Code C | —545,450 | filing |
| 6 Feb 2024filed 8 Feb 2024 | GUTS Fractyl Healthoption or derivative · Medical Devices | SEC FORM 4 Code C | —373,021 | filing |
| 6 Feb 2024filed 8 Feb 2024 | GUTS Fractyl Healthoption or derivative · Medical Devices | SEC FORM 4 Code C | —1,598,225 | filing |
| 6 Feb 2024filed 8 Feb 2024 | GUTS Fractyl HealthMedical Devices | SEC FORM 4 Code C | —5,160,301 | filing |
| 6 Feb 2024filed 8 Feb 2024 | GUTS Fractyl HealthMedical Devices | SEC FORM 4 Code C | —918,567 | filing |
| 6 Feb 2024filed 8 Feb 2024 | GUTS Fractyl HealthMedical Devices | SEC FORM 4 Bought | $5.0M333,333 at $15.00 | filing |
| 1 Feb 2024filed 5 Feb 2024 | GUTS Fractyl Healthoption or derivative · Medical Devices | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 10 Aug 2021filed 12 Aug 2021 | IVVD InvivydBiotechnology | SEC FORM 4 Code C | —9,244,580 | filing |
News
Fractyl Health Stock Plunges 48% Despite Positive Revita Weight-Maintenance Trial ResultsGUTS · rttnews.com · 16 Oct 2026Analyzing Zealand Pharma A/S (OTCMKTS:ZLDPF) & Fractyl Health (NASDAQ:GUTS)GUTS · themarketsdaily.com · 14 Oct 2026Robbins LLP Reminds Fractyl Health, Inc. Stockholders of the October 20, 2026 Lead Plaintiff Deadline - GUTS Investors Should Contact the Firm for Information About Leading the Class ActionGUTS · prnewswire.com · 13 Oct 2026
0 headlines in the last 90 days name Ajay Royan; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.